Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.87 - $2.91 $23,936 - $37,248
-12,800 Reduced 23.27%
42,200 $80,000
Q3 2021

Nov 15, 2021

BUY
$3.01 - $4.12 $38,227 - $52,324
12,700 Added 30.02%
55,000 $166,000
Q2 2021

Aug 11, 2021

SELL
$3.62 - $5.23 $159,642 - $230,643
-44,100 Reduced 51.04%
42,300 $165,000
Q1 2021

May 17, 2021

BUY
$3.94 - $8.19 $280,134 - $582,309
71,100 Added 464.71%
86,400 $438,000
Q4 2020

Feb 16, 2021

SELL
$3.99 - $5.7 $33,117 - $47,310
-8,300 Reduced 35.17%
15,300 $63,000
Q3 2020

Nov 16, 2020

BUY
$4.38 - $6.43 $29,784 - $43,724
6,800 Added 40.48%
23,600 $115,000
Q1 2020

May 15, 2020

SELL
$2.36 - $9.86 $23,364 - $97,614
-9,900 Reduced 37.08%
16,800 $55,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $94,785 - $140,175
26,700
26,700 $105,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.